Registered entities
Aardvark Therapeutics, Inc.
Reg. No. 82-1606367United States
Social engagement
Social engagement: 3.8K social following, 9 posts in the last 12 months — top quartile of its industry.
Investor mix
18 investors on record; lead investors include Sorrento Therapeutics, Vickers Venture Partners, Premier Partners, Decheng Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 39% |
| Private equity | 1 | 6% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 9 | 50% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
23 Dec 2025 · Contracts Manager
Based on job postings tracked across public sources.
Recent activity
7 May 2026
Milestone
revenue
27 Feb 2026
Product launch
Phase 3 HERO trial for the treatment of hyperphagia in Prader-Willi Syndrome
12 Feb 2026
Leadership hire
Chief Business Officer